Medicine & Health

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

WashU Medicine faculty members Mary M. Mullen, MD, an assistant professor in gynecologic oncology, and Siyan “Stewart” Cao, MD, PhD, an assistant professor in gastroenterology, have received the Young Physician-Scientist Award from the American Society for Clinical Investigation.

David Wang, an acclaimed microbiologist and virologist at WashU Medicine, is known for his work identifying new viruses and understanding their roles in human diseases.

A new adaptive model created at WashU improves surgical predictions across evolving patient populations.

Super-resolution functional photoacoustic microscopy, a new technique developed at WashU, allows researchers to image blood flow and oxygenation at single-cell resolution. The research could provide insight into microvascular health and disease, such as stroke, vascular dementia and Alzheimer’s disease.

WashU Medicine researchers made and tested a new compound in mice that shows promise in protecting the liver from damage and improving nutrient absorption after small bowel resection surgery.

Researchers at WashU have developed vulnerability maps highlighting regions across the United States with varying levels of socioeconomic vulnerability to influenza-like illness.

During WashU Medicine’s 2026 Martin Luther King Jr. Commemoration Week, 22 faculty, staff and students were recognized with Drum Major Awards for embodying King’s work and words.

The annual Assistive Tech Make-a-Thon brings together WashU OT and engineering students to enhance the lives of St. Louisans who have disabilities.

WashU Medicine researchers have shown in a new study that GLP-1 medications, typically used for diabetes and weight loss, may be effective at treating and preventing substance use disorders, from alcohol to cigarettes to opioids.